Bilateral Uterine Artery Ligation During the Cesarean Delivery of Twins
NCT ID: NCT04518176
Last Updated: 2020-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
400 participants
INTERVENTIONAL
2020-09-01
2022-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bilateral Uterine Artery Ligation in Reducing Incidence of Postpartum Hemorrhage in Cesarean Section
NCT03591679
Topical Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Women With Twin Pregnancy
NCT05072873
Buccal Misoprostol Versus IV Oxytocin in Prevention of Postpartum Hemorrhage
NCT03676621
Topical Tranexamic Acid Plus Bilateral Uterine Artery Ligation During Cesarean Delivery
NCT03741075
Intravenous Ketamine and Postoperative Pain Following Cesarean Section.
NCT03018301
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
patients with twin pregnancy undergoing cesarean section underwent bilateral uterine artery ligation and received oxytocin.
bilateral uterine artery ligation
The peritoneum over the vesico-uterine pouch already being incised horizontally, the peritoneum over the uterine isthmus and cervix was dissected downwards, and this dissection was then extended laterally
Oxytocin
20 units by slow intravenous drip injection
control group
patients with twin pregnancy undergoing cesarean section received oxytocin only.
Oxytocin
20 units by slow intravenous drip injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bilateral uterine artery ligation
The peritoneum over the vesico-uterine pouch already being incised horizontally, the peritoneum over the uterine isthmus and cervix was dissected downwards, and this dissection was then extended laterally
Oxytocin
20 units by slow intravenous drip injection
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* twin pregnancy
Exclusion Criteria
* Ante-partum hemorrhage.
* patient refuse to participate
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aswan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
hany farouk
A Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
nahla w Shady, md
Role: STUDY_CHAIR
Aswan universirty
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aswan University Hospital
Aswān, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
aswu/279/8/18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.